Grace Osborne serves as Executive at IRIS BIOTECHNOLOGIES INC, where they oversee executive responsibilities. Since joining the company, Grace Osborne has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 8, 2009 involved transacting 20,625 shares valued at $20.6K.
Grace Osborne currently holds 58,125 shares of IRIS BIOTECHNOLOGIES INC (IRSB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Grace Osborne has been a net neutral trader of IRSB stock. They have purchased $0 and sold $0 worth of shares.
Grace Osborne's most recent insider trade was on Apr 8, 2009, when they sold 20,625 shares at $1.00 per share.
Get notified when new Form 4 filings are submitted
| 27,500 |
| $0.50 |
| Discretionary |